Newpath Management, L.P.: A venture capital firm operating in Massachusetts and Florida.
6
Operating
2018
Boston, MA, US
Newpath Management is a venture capital firm focused on early-stage investments in the biotechnology and healthcare sectors. Operating primarily in Massachusetts and Florida, the firm typically participates in Seed, Series A, and Series B funding rounds, with investments ranging from $20 million to $270 million.
The firm's portfolio includes notable companies such as Chroma Medicine, Exo Therapeutics, and Orbital Therapeutics. Newpath Management demonstrates a strong commitment to advancing innovative therapeutic approaches and medical technologies, providing financial support and strategic guidance to help portfolio companies accelerate their growth and development in the life sciences industry.
Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies7
Follow-on Investments3
Current Portfolio Count6
Total Portfolio Exits1
Top Investment Stages
Series A4 (44.4%)
Seed3 (33.3%)
Series B2 (22.2%)
Stage Mix
Series A 44%Seed 33%Series B 22%
Concentration shown as share of disclosed investments by stage.
